Sunday, July 5, 2026
🇺🇸 FDA

Pharmaceutical Calculators

LOD / LOQ Calculator

Calculate Limit of Detection (LOD) and Limit of Quantitation (LOQ) per ICH Q2(R1). Supports signal-to-noise ratio and calibration curve linear regression — built for QC method validation, impurity methods, and stability-indicating assay development.

Quick Answer

LOD (Limit of Detection) is the lowest analyte concentration reliably detected; LOQ is the lowest accurately quantified. Per ICH Q2(R1), regression methods use LOD = 3.3σ/S and LOQ = 10σ/S where σ is residual standard deviation and S is calibration slope. Signal-to-noise uses S/N ≥ 3:1 for LOD and ≥ 10:1 for LOQ. QC labs validate impurity and assay methods by confirming precision (RSD ≤ 10%) and accuracy (80–120% recovery) at the LOQ level.

ICH Q2(R1) Formulas
LOD = 3.3σ / S     LOQ = 10σ / S
σ = standard deviation of the response (blank or calibration residuals)
S = slope of the calibration curve
Signal-to-Noise:   LOD at S/N ≥ 3:1    LOQ at S/N ≥ 10:1

LOD / LOQ Calculator

Choose signal-to-noise or calibration curve regression per ICH Q2(R1) to calculate limit of detection and quantitation.

Signal-to-noise inputs
In instrument response units (AU, mAU, counts, etc.)
Response units per concentration unit (e.g. AU per mg/mL)
Used to label the output
LOD
—
LOQ
—
LOQ / LOD Ratio
—
(should be ~3.3)
Calibration data

Enter calibration data pairs (minimum 3 points). The calculator fits a linear regression and calculates LOD = 3.3σ/S and LOQ = 10σ/S per ICH Q2(R1).

# Concentration (x) Response (y)
Enter if using std dev of blank responses instead of residuals
R² below 0.98 may indicate poor linearity — review calibration data before using these results.
LOD
—
LOQ
—
Slope (S)
—
Intercept (b)
—
R²
—
σ (Residuals)
—

How to Use

1
Choose Method A (Signal-to-Noise) or Method B (Calibration Curve regression per ICH Q2(R1)).
2
Method A: Enter the baseline noise (peak-to-peak or RMS) and the signal response per unit of analyte concentration.
3
Method B: Enter calibration data pairs (concentration, response) — minimum 3 points. The calculator fits a linear regression and derives σ from residuals.
4
Results show LOD and LOQ in your concentration units. Method B also displays the calibration equation (y = mx + b) and R².

Worked Example

Method B — HPLC Assay Calibration

Calibration data for an HPLC assay. Linear regression gives:

Slope S = 45,000 AU/(mg/mL)    Intercept b = 1,200 AU    σ (std dev of residuals) = 2,100 AU

LOD = (3.3 × 2,100) / 45,000 = 6,930 / 45,000 = 0.154 mg/mL

LOQ = (10 × 2,100) / 45,000 = 21,000 / 45,000 = 0.467 mg/mL

Pharma & QC method validation context

LOD and LOQ are required validation parameters for impurity methods, limit tests, and stability-indicating assays under ICH Q2(R1) and USP <1225>. QC teams calculate preliminary limits during method development, then confirm LOQ with precision and accuracy studies before filing validation reports for NDA/ANDA analytical procedures.

This calculator integrates with the NovaPharmaNews lab hub: prepare dilutions with the Dilution Calculator, plan serial dilutions with the Serial Dilution Calculator, convert concentrations with the Molarity Calculator, and assess process capability with Process Capability Cpk.

Validation protocols should document the σ source (blank vs residuals), calibration range, number of replicates, and acceptance criteria at LOQ. Align calculated limits with specification reporting thresholds and pharmacopoeial requirements for the specific dosage form.

Evidence & sources

Frequently Asked Questions

LOD (Limit of Detection) is the lowest concentration of an analyte that can be reliably detected with statistical confidence, typically defined as a signal-to-noise ratio of 3:1. LOQ (Limit of Quantitation) is the lowest concentration that can be accurately and precisely quantified, typically defined as S/N ≥ 10:1 or demonstrating acceptable accuracy (80–120%) and precision (RSD ≤ 10%) at that level.
ICH Q2(R1) Validation of Analytical Procedures: Text and Methodology covers LOD and LOQ as required validation parameters for impurity methods and limit tests. ICH Q2(R2) draft (2022) refines detection and quantitation limit approaches with updated terminology (DL/QL). The guideline describes three approaches: signal-to-noise ratio, standard deviation of the response divided by slope, and visual evaluation.
The signal-to-noise (S/N) approach uses instrumental baseline noise directly — simple but dependent on accurate noise measurement near the detection limit. The regression approach (3.3σ/S and 10σ/S) uses variability of calibration curve responses where σ is the standard deviation of residuals and S is slope. The regression approach is preferred for chromatographic methods like HPLC where baseline noise can be difficult to measure precisely at low concentrations.
Report the method used (S/N or regression), calculated LOD and LOQ values with units, calibration curve equation and R² for the regression approach, and the number of calibration points. For LOQ, demonstrate acceptable accuracy (recovery 80–120%) and precision (RSD ≤ 10%) at the LOQ level with at least 5–6 replicate injections. Include raw data and statistical summary in the validation report per ICH Q2 and USP <1225>.
R² (coefficient of determination) measures how well the data fits the linear model — values range from 0 to 1, where 1 indicates a perfect linear fit. R² ≥ 0.999 is typically expected for pharmaceutical analytical methods; ≥ 0.998 is a common minimum per regulatory guidelines. An R² below 0.98 suggests poor linearity and may require investigation of the calibration range, sample preparation, or matrix effects.
Use blank standard deviation when replicate blank injections are available and the blank response is independent of the calibration curve — common for trace impurity methods. Use residual standard deviation from linear regression when calibration data spans the working range and blank response is near zero or incorporated in the intercept. ICH Q2(R1) permits both; document the rationale in the validation protocol.
The validated range typically extends from LOQ to the highest linear concentration. Results below LOQ should not be reported as quantitative values — they may be reported as less than LOQ or not detected depending on SOP. Reporting thresholds for impurities in drug products often exceed calculated LOQ to ensure reliable quantitation at specification limits. Align LOQ with the lowest specification level requiring quantitation.
At LOQ, ICH Q2(R1) expects precision (repeatability RSD) typically ≤ 10% and accuracy (recovery) within 80–120% of the true value, though product-specific protocols may define tighter limits. Demonstrate these with at least 5–6 replicate injections at LOQ concentration. LOQ is not validated by calculation alone — empirical confirmation at the calculated level is required.
Yes, for the regression approach. A minimum of 5–6 calibration levels with replicate injections is recommended for robust linear regression, though this calculator accepts 3 points for preliminary estimates. Final validation reports should use the full calibration design specified in the analytical procedure validation protocol. Single-point or two-point calibrations are not suitable for LOD/LOQ regression.
ICH Q2(R2) draft uses Detection Limit (DL) and Quantitation Limit (QL) instead of LOD/LOQ, with refined approaches for chromatographic and spectroscopic methods. The 3.3σ/S and 10σ/S multipliers and S/N ratios remain conceptually similar. Sites transitioning to Q2(R2) should update validation protocols and report templates when the guideline is finalized in ICH regions.
When both limits are calculated from the same σ and S using ICH regression formulas, LOQ/LOD = (10σ/S) ÷ (3.3σ/S) = 10/3.3 ≈ 3.03. A ratio near 3.3 confirms consistent methodology. Deviations occur when different σ sources are used for LOD versus LOQ, or when S/N and regression methods are mixed — document any intentional difference in the validation report.
No. This calculator provides preliminary LOD/LOQ estimates for method development and protocol drafting. Formal validation requires protocol-defined calibration designs, system suitability criteria, specificity, linearity, accuracy, precision, robustness, and stability studies per ICH Q2(R1), USP <1225>, and pharmacopoeial requirements. Regulatory submissions require complete validation reports with raw data — not calculator output alone.

Related Calculators

C1V1 Dilution Calculator Serial Serial Dilution Calculator M Molarity Calculator Units Unit Converter

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.